Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Anker

Showing results (21-30 of 120) with videos related to

Pageof 12
Sort By:
Journal of the American College of Cardiology|February 11, 1999
Peak VO2 et al. for prognosis in heart failure?S D Anker, A J Coats
Lancet (London, England)|December 7, 1996
Metabolic, functional, and haemodynamic staging for CHF?S D Anker, A J Coats
Deutsche Medizinische Wochenschrift (1946)|April 12, 2014
[Iron deficiency in chronic heart failure: from diagnosis to therapy]S von Haehling, S D Anker
Circulation|January 21, 1997
Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarctionS D Anker, A J Coats
Heart Failure Monitor|March 14, 2003
Chronic heart failure as a metabolic disorderS D Anker, F O Al-Nasser
BMJ (Clinical Research Ed.)|April 9, 2001
Insulin-like growth factor-I can be helpful towards end of lifeA Bolger, W Doehner, S D Anker
Clinical Nephrology|August 28, 2003
Anemia in chronic heart failure--frequency and prognostic impactW Steinborn, W Doehner, S D Anker
The American Journal of Cardiology|November 13, 2001
Antiendotoxin antibody levels in unstable angina: lessons from chronic heart failure and cardiopulmonary bypassA P Bolger, M Rashid, S D Anker
Herzschrittmachertherapie & Elektrophysiologie|March 30, 2012
[Commentary on the 2010 ESC guidelines on device therapy in heart failure ]C W Israel, S D Anker, G Hasenfuss, et al.
Journal of the American College of Cardiology|February 24, 2001
Vascular effect of insulin in endothelial dysfunctionW Doehner, I F Godsland, S D Anker
Pageof 12

Showing results (21-30 of 120) with videos related to

Sort By:
Pageof 12
Journal of the American College of Cardiology|February 11, 1999
Peak VO2 et al. for prognosis in heart failure?S D Anker, A J Coats
Lancet (London, England)|December 7, 1996
Metabolic, functional, and haemodynamic staging for CHF?S D Anker, A J Coats
Deutsche Medizinische Wochenschrift (1946)|April 12, 2014
[Iron deficiency in chronic heart failure: from diagnosis to therapy]S von Haehling, S D Anker
Circulation|January 21, 1997
Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarctionS D Anker, A J Coats
Heart Failure Monitor|March 14, 2003
Chronic heart failure as a metabolic disorderS D Anker, F O Al-Nasser
BMJ (Clinical Research Ed.)|April 9, 2001
Insulin-like growth factor-I can be helpful towards end of lifeA Bolger, W Doehner, S D Anker
Clinical Nephrology|August 28, 2003
Anemia in chronic heart failure--frequency and prognostic impactW Steinborn, W Doehner, S D Anker
The American Journal of Cardiology|November 13, 2001
Antiendotoxin antibody levels in unstable angina: lessons from chronic heart failure and cardiopulmonary bypassA P Bolger, M Rashid, S D Anker
Herzschrittmachertherapie & Elektrophysiologie|March 30, 2012
[Commentary on the 2010 ESC guidelines on device therapy in heart failure ]C W Israel, S D Anker, G Hasenfuss, et al.
Journal of the American College of Cardiology|February 24, 2001
Vascular effect of insulin in endothelial dysfunctionW Doehner, I F Godsland, S D Anker
Pageof 12